In conversation with Niek Stapel, CEO of Veranova

See more

How can today’s CDMOs ensure they can meet tomorrow’s demands?

See more

Leading the way in Synthetic Chemistry

See more

Veranova at CPHI WW

See more

JM Health rebrands as Veranova following sale to Altaris Capital Partners

See more

Featured insights from our experts

Read more

The importance of chirality in API development

The chirality of a molecule can influence key pharmacological activities, which impact a drug’s tolerability, safety, and bioavailability.

Ultra-pure synthetic cannabidiol (CBD)

We’re utilising our scientific and manufacturing expertise to develop and commercialize ultra-pure synthetic…

Early form screening strategies to accelerate candidate selection

Failure to select a successful candidate can be expensive in terms of both time and money.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us